Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
140-82-9
17626-34-5
23978-09-8
31249-95-3
23978-55-4
70384-51-9
54384-47-3 | 2-(2-([2-(2-Hydroxyethoxy)ethyl]amino)ethoxy)ethan-1-ol | AA019E3V | MFCD00239212
2112730-79-5 | N-(Biotin-peg4)-n-bis(peg4-t-butyl ester) | AA019E8U | MFCD30723259
894414-29-0 | (1,3-dioxoisoindolin-2-yl)-propan-NH-Boc | AA019ED5 | MFCD09923400
1840886-10-3 | DBCO-CONH-PEG4-amine | AA019EH3 | MFCD22380748
107289-03-2 | 4-Isopropylquinazolin-2(1H)-one | AA019EKE | MFCD24559421
30034-49-2 | 3-Methoxy-4-(benzyloxy)-benzenepropanoic acid | AA019EN3 | MFCD00185555
124369-60-4 | 5-Bromo-3,3-dimethyl-2,3-dihydro-1H-inden-1-ol | AA019EQ6 | MFCD27942516
71083-55-1 | 6,8-difluoroquinoline-3-carbonitrile | AA019EUA | MFCD27927783
685106-60-9 | 4-Oxo-5-(thiophen-2-ylmethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-3-carboxylic acid | AA019EWZ | MFCD03617329
1521871-43-1 | 3-(pyridin-3-yl)cyclobutan-1-amine | AA019FBL | MFCD23841570